AdventHealth Global Robotics Institute

04/15/2026

Can we really trust MRI to rule out seminal vesicle invasion?

Our recent study challenges that assumption and more importantly, shows what to do about it.
What we found MRI has very high specificity (99%) but poor sensitivity (~17%) for SVI 83% of SVI cases are missed on imaging

Key predictors go beyond MRI:
Basal tumor involvement on biopsy
Higher PSA and % positive cores
Grade Group ≥3
MRI indirect signs (ECE, lesion
location) Why it matters clinically
A negative MRI does NOT exclude SVI. Relying on imaging alone risks understaging and suboptimal surgical planning

The big picture This is a shift from imaging-based decisions to integrated risk assessment.

The future isn’t MRI vs. clinical data-it’s the combination of:

Imaging
Biopsy mapping
Clinical variables
(Soon) genomics and PSMA PET

Bottom line:

If you’re planning surgery or radiation based on MRI alone... you’re probably missing the full story.

04/14/2026

Thank you, Dr. Ozawa, for your continued hard work and for sharing this article.

MRI’ sensitivity of detecting Seminal vesicle invasion is < 60% (specificity 95%). Even when MRI is negative, indirect information (tumor location on MRI, systematic biopsy findings etc) helps up assess risk of seminal vesicle invasion.

04/14/2026

Congratulations, Dr. Ozawa, on this incredible accomplishment and the publication of your article!

New score makes evaluating genetic risk (GPS, Oncotype) as simple as checking PSA and Gleason score. Thank you for your help with this.

03/30/2026

https://acrobat.adobe.com/id/urn:aaid:sc:VA6C2:7b2e9643-a9c8-4958-8903-8116d59bd8cc

By our fellow: Dr. Yu Ozawa

Findings
💡Genomic prostate score (GPS, Oncotype) improves prediction of adverse pathology at radical prostatectomy when added to MRI and PSA density, particularly in intermediate-risk patients.

💡Its value is most pronounced in intermediate risk cases where decision-making between active surveillance and definitive therapy remains clinically uncertain, rather than in clinically low-risk groups (selective use)

Many thanks to all who contributed to and supported this work.

03/17/2026

Who really makes robotic surgery safe, the console surgeon or the entire team?

Our study published in BJU International highlights a critical but often overlooked role in robotic surgery: the patient-side assistant.

While most robotic training programs focus on the console surgeon, this work from the European Association of Urology robotic and young academic groups validates structured performance metrics to objectively evaluate bedside assistant skills during robot-assisted radical prostatectomy.

• Why it matters

Robotic surgery is a team-based procedure.

The bedside assistant is essential for exposure, instrument exchange, troubleshooting, and maintaining surgical flow.

Going deeper

The study proposes proficiency-based training metrics and identifies critical errors, moving robotic education toward objective competency-based assessment.

® The big picture
As robotics expands, and especially with teleproctoring and telesurgery, the quality of the local surgical team becomes even more important.
Robotic surgery is not only about mastering the console.

02/10/2026

I am happy to share that our paper on very high risk decipher score >0.85 has been featured as a highlight on the European Urology Oncology cover page. One of the reputed Journal across the world.

Thank you Professor Vipul Patel and the entire GRI team for the continued support…💐💐

- Dr. Rohan Sharma

02/05/2026

How education and early screening improve prostate cancer outcomes

https://www.axios.com/sponsored/how-education-and-early-screening-improve-prostate-cancer-outcomes

01/29/2026

Where compassion meets results.

Congratulations to our 20,000th patient on a successful surgical recovery, highlighting the impact of thoughtful, coordinated care.

01/22/2026

http://www.aroundosceola.com/news/adventhealth-surgeon-using-landmark-robotic-procedure-call-earlier-prostate-screening

Fifty-year-old U.S. Air Force Col. Brandon Kelly and AdventHealth Celebration’s Global Robotics Institute medical director and surgeon Dr. Vipul Patel became part of history earlier this month on Veteran’s Day.

01/20/2026

Dr. Patel and his team have just completed 10 telesurgery cases from Celebration, Florida to Luanda, Angola with their groundbreaking work conducted as part of the first FDA-approved clinical research study involving telesurgery.

01/05/2026

We're humbled to share that ABC News recognized a groundbreaking remote robotic surgery led by Dr. Vipul Patel at AdventHealth Celebration as one of the top medical breakthroughs of 2025. This innovation is helping bring specialized care closer to patients and families around the world no matter the distance.

Learn more:

ABC News has named a groundbreaking remote robotic surgery led by Dr. Vipul Patel, medical director of the Global Robotics Institute at AdventHealth Celebration, one of the top medical breakthroughs of 2025.

12/31/2025

https://abcnews.go.com/Health/groundbreaking-robotic-surgery-alzheimers-blood-test-7-biggest/story?id=128654798

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a year full of medical breakthroughs.